BI
PFE icon

Berkeley Inc’s Pfizer PFE Stock Holding History

Berkeley Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,682
Closed -$852K – 79
2023
Q3 		$852K Buy
25,682
+1,217
+5% +$43K 0.58% 39
2023
Q2 		$897K Buy
24,465
+940
+4% +$36.6K 0.6% 37
2023
Q1 		$960K Buy
23,525
+917
+4% +$39.6K 0.7% 35
2022
Q4 		$1.16M Sell
22,608
-2,494
-10% -$120K 0.87% 29
2022
Q3 		$1.1M Sell
25,102
-3,855
-13% -$187K 0.93% 27
2022
Q2 		$1.52M Buy
28,957
+23,340
+416% +$1.19M 1.22% 24
2022
Q1 		$291K Sell
5,617
-37
-0.7% -$1.92K 0.2% 77
2021
Q4 		$334K Buy
5,654
+25
+0.4% +$1.24K 0.22% 70
2021
Q3 		$242K Buy
5,629
+29
+0.5% +$1.28K 0.18% 76
2021
Q2 		$219K Sell
5,600
-8,540
-60% -$332K 0.16% 78
2021
Q1 		$512K Buy
+14,140
New +$502K 0.38% 53

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Berkeley Inc's PFE Position: Q4 2023 in Review

Berkeley Inc sold out of Pfizer (PFE) in Q4 2023, closing a stake of 25,682 shares — an estimated $852K sold.

Berkeley Inc first reported a position in PFE in Q1 2021 and held it in 11 quarters. The position peaked at $1.52M in Q2 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Berkeley Inc reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Berkeley Inc sold 25,682 Pfizer shares in Q4 2023, an estimated $852K.
  • Berkeley Inc first reported a position in Pfizer in Q1 2021 and held it in 11 quarters.
  • Berkeley Inc's Pfizer position peaked at $1.52M in Q2 2022.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Berkeley Inc's 13F filing for Q4 2023, filed 4 Mar 2025.